Literature DB >> 18068480

Validation of World Health Organization/International Society of Urologic Pathology 2004 classification schema for bladder urothelial carcinomas using quantitative nuclear morphometry: identification of predictive features using bootstrap method.

Umesh Kapur1, Tatjana Antic, Girish Venkataraman, Ramon Durazo-Arvizu, Marcus M Quek, Robert C Flanigan, Eva M Wojcik.   

Abstract

OBJECTIVES: Despite the introduction of the new World Health Organization 2004 grading classification, the grading of urothelial carcinoma remains difficult and subjective. The aim of this study was to evaluate the role of computer-assisted image morphometric analysis as a tool to improve the objectivity of histologic grading of urothelial carcinoma.
METHODS: A total of 75 urinary bladder biopsies from a cohort of patients with a first-time diagnosis of urothelial carcinoma representing low-grade (n = 19) and high-grade (n = 56) urothelial carcinoma were evaluated. Quantitative nuclear morphometry was performed on these biopsies using approximately 80 to 100 cells per case. A total of 17 nuclear morphometry features were extracted, and a bootstrap-based predictor selection using stepwise logistic regression analysis was performed. Subsequently, a validation was performed using the five top features from the logistic regression analyses by implementing a nonparametric discriminant analysis to identify the most discriminative features that predicted for high-grade cases.
RESULTS: The bootstrap technique included nuclear pleomorphism as the most frequently selected predictor of high-grade urothelial carcinoma (in 213 of 500 replicates). Validation using the top five features in the logistic regression analysis method (pleomorphism, configuration run length, DNA mass, feret-Y, and age) using discriminant analysis gave a resubstitution error of 4%, indicating the usefulness of the selected predictors.
CONCLUSIONS: The present study is the first to provide a morphometric validation of the World Health Organization 2004 system for pathologic grading of bladder cancer. Furthermore, quantitative nuclear morphometry could aid in the objective grading of urinary bladder biopsies. This information might aid the treating physicians in better risk stratification of patients with urothelial carcinoma.

Entities:  

Mesh:

Year:  2007        PMID: 18068480     DOI: 10.1016/j.urology.2007.09.003

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Decreased expression of protein tyrosine phosphatase non-receptor type 12 is involved in the proliferation and recurrence of bladder transitional cell carcinoma.

Authors:  Yongrui Piao; Xiankui Liu; Zhenhua Lin; Zhehu Jin; Xuanshun Jin; Kuichang Yuan; Wenyuan Wu
Journal:  Oncol Lett       Date:  2015-07-03       Impact factor: 2.967

2.  Computerized nuclear morphometry in the diagnosis of thyroid lesions with predominant follicular pattern.

Authors:  Ha Aiad; Ag Abdou; Ma Bashandy; An Said; Ss Ezz-Elarab; Aa Zahran
Journal:  Ecancermedicalscience       Date:  2009-09-17

3.  Role of morphometry and proliferative parameters in grading of urothelial neoplasms.

Authors:  Monika Sangwan; Sunita Singh; Santosh Kumar; Sonia Chabbra; Rajeev Sen; Praveen Rana; Shivani Malik; Sonia Singh; Ramesh Lamba
Journal:  Cent European J Urol       Date:  2015-03-13

4.  Morphometric Analysis of Thyroid Follicular Cells with Atypia of Undetermined Significance.

Authors:  Youngjin Kang; Yoo Jin Lee; Jiyoon Jung; Youngseok Lee; Nam Hee Won; Yang Seok Chae
Journal:  J Pathol Transl Med       Date:  2016-06-13

5.  Cytological Evaluation of Thyroid Lesions by Nuclear Morphology and Nuclear Morphometry.

Authors:  R Yashaswini; T N Suresh; A Sagayaraj
Journal:  J Cytol       Date:  2017 Oct-Dec       Impact factor: 1.000

6.  Study of Proliferating cell nuclear antigen expression and Angiogenesis in Urothelial neoplasms: Correlation with tumor grade and stage.

Authors:  Poojan Agarwal; Achin Kumar Sen; Minakshi Bhardwaj; Veronique Dinand; Arvind Ahuja; Rajeev Sood
Journal:  Urol Ann       Date:  2018 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.